News
Bitcoin Miners Dominate the List. Summit Therapeutics Inc. (NASDAQ:SMMT) is one of Wednesday’s top performers. Summit ...
Summit Therapeutics' HARMONi trial data for ivonescimab showed a clinical benefit but narrowly missed statistical ...
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 10 Stocks Going Wild. Summit Therapeutics jumped by 7.61 percent on ...
Summit Therapeutics (NASDAQ:SMMT) shares spiked on Thursday, triggering a trading halt after Bloomberg News reported that AstraZeneca (NASDAQ:AZN) is in discussions to strike a licensing deal with ...
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. Analysts at H.C. Wainwright reaffirmed their Buy rating on Summit ...
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...
AstraZeneca PLC (NASDAQ:AZN) is one of the best high growth stocks. Bloomberg reported on July 3 that AstraZeneca is engaged ...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Summit Therapeutics Inc. ("Summit" or "the Company") (NASDAQ: ...
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, ...
14d
InvestorsHub on MSNSummit Therapeutics Shares Climb Amid Rumored $15B Deal Talks with AstraZenecaShares of Summit Therapeutics (NASDAQ:SMMT) jumped 5% on Thursday following reports that the company is in advanced negotiations with AstraZeneca (NASDAQ:AZN) over a potential multi-billion-dollar ...
In trading on Tuesday, shares of Summit Therapeutics Inc (Symbol: SMMT) crossed above their 200 day moving average of $20.88, changing hands as high as $21.82 per share. Summit Therapeutics Inc ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results